Literature DB >> 17924347

Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Bhuvarahamurthy Venugopal1, Marsha F Browning, Cyntia Curcio-Morelli, Andrea Varro, Norman Michaud, Nanda Nanthakumar, Steven U Walkley, James Pickel, Susan A Slaugenhaupt.   

Abstract

Mucolipidosis type IV (MLIV) is an autosomal recessive lysosomal storage disorder caused by mutations in the MCOLN1 gene, which encodes the 65-kDa protein mucolipin-1. The most common clinical features of patients with MLIV include severe mental retardation, delayed motor milestones, ophthalmologic abnormalities, constitutive achlorhydria, and elevated plasma gastrin levels. Here, we describe the first murine model for MLIV, which accurately replicates the phenotype of patients with MLIV. The Mcoln1(-/-) mice present with numerous dense inclusion bodies in all cell types in brain and particularly in neurons, elevated plasma gastrin, vacuolization in parietal cells, and retinal degeneration. Neurobehavioral assessments, including analysis of gait and clasping, confirm the presence of a neurological defect. Gait deficits progress to complete hind-limb paralysis and death at age ~8 mo. The Mcoln1(-/-) mice are born in Mendelian ratios, and both male and female Mcoln1(-/-) mice are fertile and can breed to produce progeny. The creation of the first murine model for human MLIV provides an excellent system for elucidating disease pathogenesis. In addition, this model provides an invaluable resource for testing treatment strategies and potential therapies aimed at preventing or ameliorating the abnormal lysosomal storage in this devastating neurological disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17924347      PMCID: PMC2265643          DOI: 10.1086/521954

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  72 in total

Review 1.  Cell biology of acid secretion by the parietal cell.

Authors:  Xuebiao Yao; John G Forte
Journal:  Annu Rev Physiol       Date:  2002-08-05       Impact factor: 19.318

2.  Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway.

Authors:  Janice M LaPlante; John Falardeau; Mei Sun; Marie Kanazirska; Edward M Brown; Susan A Slaugenhaupt; Peter M Vassilev
Journal:  FEBS Lett       Date:  2002-12-04       Impact factor: 4.124

Review 3.  TRPpathies.

Authors:  Kirill Kiselyov; Abigail Soyombo; Shmuel Muallem
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

Review 4.  TRPML and lysosomal function.

Authors:  David A Zeevi; Ayala Frumkin; Gideon Bach
Journal:  Biochim Biophys Acta       Date:  2007-01-19

5.  Review article: mucolipidosis IV.

Authors:  B F Crandall; M Philippart; W J Brown; D A Bluestone
Journal:  Am J Med Genet       Date:  1982-07

6.  Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy.

Authors:  I Tellez-Nagel; I Rapin; T Iwamoto; A B Johnson; W T Norton; H Nitowsky
Journal:  Arch Neurol       Date:  1976-12

7.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

8.  Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI.

Authors:  Oliver F Strauch; Jörg Stypmann; Thomas Reinheckel; Elke Martinez; Wilhelm Haverkamp; Christoph Peters
Journal:  Pediatr Res       Date:  2003-08-06       Impact factor: 3.756

9.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

10.  Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.

Authors:  Monica Cardone; Vinicia Assunta Polito; Stefano Pepe; Linda Mann; Alessandra D'Azzo; Alberto Auricchio; Andrea Ballabio; Maria Pia Cosma
Journal:  Hum Mol Genet       Date:  2006-02-27       Impact factor: 6.150

View more
  76 in total

1.  Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy.

Authors:  David A Zeevi; Shaya Lev; Ayala Frumkin; Baruch Minke; Gideon Bach
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis.

Authors:  Mohammad Samie; Xiang Wang; Xiaoli Zhang; Andrew Goschka; Xinran Li; Xiping Cheng; Evan Gregg; Marlene Azar; Yue Zhuo; Abigail G Garrity; Qiong Gao; Susan Slaugenhaupt; Jim Pickel; Sergey N Zolov; Lois S Weisman; Guy M Lenk; Steve Titus; Marthe Bryant-Genevier; Noel Southall; Marugan Juan; Marc Ferrer; Haoxing Xu
Journal:  Dev Cell       Date:  2013-08-29       Impact factor: 12.270

4.  A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.

Authors:  Marisol Mirabelli-Badenier; Mariasavina Severino; Barbara Tappino; Domenico Tortora; Francesca Camia; Clelia Zanaboni; Fabia Brera; Enrico Priolo; Andrea Rossi; Roberta Biancheri; Maja Di Rocco; Mirella Filocamo
Journal:  Metab Brain Dis       Date:  2014-08-26       Impact factor: 3.584

Review 5.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

6.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 7.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

8.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

9.  Suppression of the motor deficit in a mucolipidosis type IV mouse model by bone marrow transplantation.

Authors:  Marquis T Walker; Craig Montell
Journal:  Hum Mol Genet       Date:  2016-06-07       Impact factor: 6.150

Review 10.  TRPML: transporters of metals in lysosomes essential for cell survival?

Authors:  Kirill Kiselyov; Grace A Colletti; Austen Terwilliger; Kathleen Ketchum; Christopher W P Lyons; James Quinn; Shmuel Muallem
Journal:  Cell Calcium       Date:  2011-05-31       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.